CYP46A1 and Huntington disease: Finally, a therapeutic approach through supplementation of the gene encoding cholesterol-24-hydroxylase (CYP46A1) has been investigated for HD, based on the rationale that this gene codes for a neuron-specific enzyme which has a role in brain cholesterol synthesis and metabolism, and is deficient in patients with HD.